Exogene Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Exogene is a biotechnology company based in Oxford, England, focused on discovering and developing T-cell receptor–based therapies for cancer. It employs a lab-in-the-loop platform that combines artificial intelligence with wet-lab work to design novel, multi-specific agents that target peptide-HLA antigens, with the aim of engaging the immune system to eradicate tumors. Positioned within the biotechnology research sector, the company operates at the intersection of immunotherapy and AI-enabled drug discovery. Exogene pursues collaborations with pharma and biotech partners to discover T-cell receptors and develop TCR-based cell therapies, with out-licensing as a potential path. In March 2024, Exogene announced a strategic collaboration with Immunocore to engineer T-cell receptors using artificial intelligence.